Mesothelioma: A study of 22 cases

Southern Medical Journal

Volumn 90, Issue 2, 1997, Pages 199-205

  King, Judy A C ^a,b   Tucker, J Allan ^a   Wong, Song W ^a  

^a University of South   (United States)

^b UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; CARCINOEMBRYONIC ANTIGEN; CD15 ANTIGEN; KERATIN;

ADULT; AGED; ARTICLE; ASBESTOSIS; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MESOTHELIOMA; METASTASIS; OCCUPATIONAL EXPOSURE; PERIODIC ACID SCHIFF STAIN; PLEURA PLAQUE;

EID: 0031048284     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-199702000-00006     Document Type: Article

References (36)

1. Wagner JC, Sleggs CA, Marchand P: Diffuse pleural mesothelioma and asbestos exposure in North Western Cap Province. Br J Ind Med 1960; 17:260-271
2. Selikoff IJ, Churg J, Hammond EC: Relation between exposure to asbestos and mesothelioma. N Engl J Med 1965; 272:560-565
3. Aisner J, Wiernik PH: Malignant mesothelioma. Current status and future prospects. Chest 1978; 74:438-444
4. Hammar SP, Dodson RF: Asbestos. Pulmonary Pathology. Dail DH, Hammar SP (eds). New York, Springer-Verlag, 2nd Ed, 1994, pp 901-983
5. Hillerdal G: Malignant mesothelioma 1982: review of 4710 published cases. Br J Dis Chest 1983; 77:321-343
6. McDonald JC: Health implications of environmental exposure to asbestos. Environ Health Perspect 1985; 62:319-328
7. Hammar SP: Pleural diseases. Pulmonary Pathology. Dail DH, Hammar SP (eds). New York, Springer-Verlag, 2nd Ed, 1994, pp 1463-1579
8. King JAC, Wong S: Quantitation of ferruginous bodies by digestion of lung tissue (Abstract). Int J Surg Pathol 1995; 2(suppl):500
9. King JAC, Wong SW: Autopsy evaluation of asbestos exposure: retrospective study of 135 cases with quantitation of ferruginous bodies in digested lung tissue. South Med J 1996; 89:380-385
10. Cook CC: Carbohydrates. Theory and Practice of Histological Techniques. Bancroft JD, Stevens A (eds). New York, Churchill-Livingstone, 1982, p 188
11. Sheehan DC, Hrapchak BB: Alcian blue method. Theory & Practice of Histotechnology. St. Louis, CV Mosby, 1980, pp 172-174
12. Luna LG (ed): Methods for carbohydrates and mucoproteins. Manual of Histological Staining Methods of the Armed Forces of Pathology. New York, McGraw-Hill, 3rd Ed, 1960, pp 171-172
13. Hughes JM, Weill H: Asbestos exposure - quantitative assessment of risk. Am Rev RespirDis 1986; 133:5-13
14. Roggli VL, Pratt PC, Brody AR: Asbestos content of lung tissue in asbestos associated diseases: a study of 110 cases. Br J Ind Med 1986; 43:18-28
15. Berry G, Newhouse ML, Antonis P: Combined effect of asbestos and smoking on mortality from lung cancer and mesothelioma in factory workers. Br J Ind Med 1985; 42:12-18
16. Muscat JE, Wynder EL: Cigarette smoking, asbestos exposure, and malignant mesothelioma. Cancer Res 1991; 51:2263-2267
17. Roggli VL, McGavran MH, Subach J, et al: Pulmonary asbestos body counts and electron probe analysis of asbestos body cores in patients with mesothelioma: a study of 25 cases. Cancer 1982; 50:2423-2432
18. Chen W, Mottet NK: Malignant mesothelioma with minimal asbestos exposure. Hum Pathol 1978; 9:253-258
19. Epler GR, Fitz Gerald MX, Gaensler EA, et al: Asbestos-related disease from household exposure. Respiration 1980; 39:229-240
20. Newhouse ML, Berry G: Predictions of mortality from mesothelial tumours in asbestos factory workers. Br J Ind Med 1976; 33:147-151
21. Newhouse ML, Berry G: Patterns of mortality in asbestos factory workers in London. Ann NY Acad Sci 1979; 330:53-60
22. Tuomi T, Huuskonen MS, Tammilehto L, et al: Occupational exposure to asbestos evaluated from work histories and analysis of lung tissues from patients with mesothelioma. Br J Ind Med 1991; 48:48-52
23. Ghosh AK, Gatter KC, Dunnill MS, et al: Immunohistological staining of reactive mesothelium, mesothelioma, and lung carcinoma with a panel of monoclonal antibodies. J Clin Pathol 1987; 40:19-25
24. Ordonez NG: The immunohistochemical diagnosis of mesothelioma: differentiation of mesothelioma and lung adenocarcinoma. Am J Surg Pathol 1989; 13:276-291
25. Said JW, Nash G, Tepper G, et al: Keratin proteins and carcinoembryonic antigen in lung carcinoma: an immunoperoxidase study of fifty-four cases, with ultrastructural correlations. Hum Pathol 1983; 14:70-76
26. Holden J, Churg A: Immunohistochemical staining for keratin and carcinoembryonic antigen in the diagnosis of malignant mesothelioma. Am J Surg Pathol 1984; 8:277-279
27. Wang N-S, Huang S-N, Gold P: Absence of carcinoembryonic antigen-like material in mesothelioma: an immunohistochemical differentiation from other lung cancers. Cancer 1979; 44:937-943
28. Corson JM, Pinkus GS: Mesothelioma: profile of keratin proteins and carcinoembryonic antigen, an immunoperoxidase study of 20 cases and comparison with pulmonary adenocarcinomas. Am J Pathol 1982; 108:80-87
29. Hammar SP, Bolen JW, Bockus D, et al: Ultrastructural and immunohistochemical features of common lung tumors: an overview. Ultrastruct Pathol 1985; 9:283-318
30. Sheibani K, Battifora H, Burke JS: Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas: an immunohistologic analysis demonstrating the value of Leu-M1 antigen. Am J Pathol 1986; 123:212-219
31. Otis CN, Carter D, Cole S, et al: Immunohistochemical evaluation of pleural mesothelioma and pulmonary adenocarcinoma: a bi-institutional study of 47 cases. Am J Surg Pathol 1987; 11:445-456
32. Wick MR, Loy T, Mills SE, et al: Malignant epithelioid pleural mesothelioma versus peripheral pulmonary adenocarcinoma: a histochemical, ultrastructural, and immunohistologic study of 103 cases. Hum Pathol 1990; 21:759-766
33. Guzman J, Bross KJ, Würtemberger G, et al: Immunocytology in malignant pleural mesothelioma: expression of tumor markers and distribution of lymphocyte subsets. Chest 1989; 95:590-595
34. Sheibani K, Battifora H, Burke JS, et al: Leu-M1 antigen in human neoplasms: an immunohistologic study of 400 cases. Am J Surg Pathol 1986; 10:227-236
35. Sheibani K, Shin SS, Kezirian J, et al: Ber-EP4 antibody as a discriminant in the differential diagnosis of malignant mesothelioma versus adenocarcinoma. Am J Surg Pathol 1991; 15:779-784
36. Bedrossian CWM, Bonsib S, Moran C: Differential diagnosis between mesothelioma and adenocarcinoma: a multimodal approach based on ultrastructure and immunocytochemistry. Semin Diagn Pathol 1992; 9:124-140